Skip to content

Past Award Winners – Distinguished Service to SER

JLyon

2015 Distinguished Service to SER Award Winner
Joseph Lynn Lyon, M.D.

Joseph Lynn Lyon is a Professor Emeritus in the Department of Family and Preventive Medicine at the University of Utah School of Medicine. He received his B.S. and M.D. degree from University of Utah, and a Master of Public Health degree from the Harvard School of Public Health.

He has published over 140 articles in the peered reviewed scientific literature. He has been the recipient of 29 grants and contracts, mostly from the U.S. National Institutes of Health and the U.S. Centers for Disease Control and Prevention. He has served as a reviewer for a number of scientific journals, including the Journal of the American Medical Association and the American Journal of Epidemiology.

Dr. Lyon has served as the Secretary-Treasurer of the SER for more than 20 years.

ssacks

2014 Distinguished Service to SER Award Winner
Susan Sacks, Ph.D.

Dr. Susan Sacks joined Syntex in 1985. Syntex was later purchased by Roche. She spent three years as a senior biostatistician in the Institute for Research Data Management doing analysis and interpretation of clinical trial data. This was followed by five years as the Manager of Epidemiology in Syntex’ Occupational Health Department where she worked closely with personnel in Environmental Health & Safety overseeing the health surveillance programs at Syntex’ chemical and pharmaceutical manufacturing plants. She then spent six years in Roche’s Pharmacoeconomics Research Department as Director of Epidemiology where she was involved in the pharmacoeconomic evaluation of several compounds in early development. In 2000, Susan became Global Head of the Epidemiology Group within the Drug Safety Risk Management Department of Roche Global Development. In this role, she and her group provided epidemiologic support to the personnel working in drug safety. The group investigated the epidemiology of adverse events which are potentially induced by pharmaceuticals. She continued working in drug safety until her retirement in 2010. Read more